FR20C1050I1 - - Google Patents
Info
- Publication number
- FR20C1050I1 FR20C1050I1 FR20C1050C FR20C1050I1 FR 20C1050 I1 FR20C1050 I1 FR 20C1050I1 FR 20C1050 C FR20C1050 C FR 20C1050C FR 20C1050 I1 FR20C1050 I1 FR 20C1050I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D505/10—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D505/12—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7
- C07D505/14—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7 with hetero atoms directly attached in position 7
- C07D505/16—Nitrogen atoms
- C07D505/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D505/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D505/24—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by doubly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008280828 | 2008-10-31 | ||
| EP09823578.1A EP2341053B1 (en) | 2008-10-31 | 2009-10-27 | Cephalosporin having catechol group |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR20C1050I1 true FR20C1050I1 (en) | 2020-11-27 |
| FR20C1050I2 FR20C1050I2 (en) | 2021-10-15 |
Family
ID=42128829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR20C1050C Active FR20C1050I2 (en) | 2008-10-31 | 2020-10-15 | CEPHALOSPORIN COMPRISING A CATECHOL GROUP |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US9238657B2 (en) |
| EP (2) | EP2341053B1 (en) |
| JP (2) | JP5498393B2 (en) |
| KR (1) | KR101655961B1 (en) |
| CN (1) | CN102203100B (en) |
| AU (1) | AU2009310959B2 (en) |
| BR (1) | BRPI0921701B8 (en) |
| CA (1) | CA2736953C (en) |
| CL (1) | CL2011000939A1 (en) |
| CO (1) | CO6331443A2 (en) |
| CR (1) | CR20110144A (en) |
| CY (2) | CY1118536T1 (en) |
| DK (1) | DK2960244T3 (en) |
| EA (1) | EA019520B1 (en) |
| ES (2) | ES2564836T3 (en) |
| FI (1) | FIC20200039I1 (en) |
| FR (1) | FR20C1050I2 (en) |
| HR (1) | HRP20161408T1 (en) |
| HU (2) | HUE031802T2 (en) |
| IL (1) | IL211720A (en) |
| LT (2) | LT2960244T (en) |
| MA (1) | MA32731B1 (en) |
| ME (1) | ME02666B (en) |
| MX (1) | MX2011004636A (en) |
| MY (1) | MY155655A (en) |
| NL (1) | NL301067I2 (en) |
| NO (1) | NO2020035I1 (en) |
| NZ (1) | NZ591728A (en) |
| PE (1) | PE20120010A1 (en) |
| PL (1) | PL2960244T3 (en) |
| PT (1) | PT2960244T (en) |
| RS (1) | RS55365B1 (en) |
| SI (1) | SI2960244T1 (en) |
| SM (1) | SMT201600397B (en) |
| TW (1) | TWI535727B (en) |
| UA (1) | UA105190C2 (en) |
| WO (1) | WO2010050468A1 (en) |
| ZA (1) | ZA201102024B (en) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8883772B2 (en) | 2007-10-09 | 2014-11-11 | Sopharmia, Inc. | Broad spectrum beta-lactamase inhibitors |
| PT2960244T (en) | 2008-10-31 | 2016-11-02 | Shionogi & Co | Cephalosporin having catechol group |
| EP2557082A4 (en) * | 2010-04-05 | 2013-08-28 | Shionogi & Co | Cephem compound having catechol group |
| US8883773B2 (en) | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
| JP5852562B2 (en) * | 2010-04-28 | 2016-02-03 | 塩野義製薬株式会社 | Novel cephem derivatives |
| CN103502218B (en) | 2011-03-04 | 2016-08-17 | 生命科技公司 | Compounds and methods for for conjugating biomolecules |
| KR101719556B1 (en) * | 2011-03-30 | 2017-03-24 | 주식회사 레고켐 바이오사이언스 | Novel cephalosporin derivatives and Pharmaceutical Compositions Comprising the Same |
| US9334289B2 (en) * | 2011-04-28 | 2016-05-10 | Shionogi & Co., Ltd. | Cephem compound having catechol or pseudo-catechol structure |
| US9242999B2 (en) | 2011-06-27 | 2016-01-26 | Shionogi & Co., Ltd. | Cephem compound having pyridinium group |
| TWI547496B (en) * | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | Antibacterial compounds |
| JPWO2013051597A1 (en) | 2011-10-04 | 2015-03-30 | 塩野義製薬株式会社 | Cephem derivatives with catechol groups |
| UY35103A (en) | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | 2-REPLACED CEFEM COMPOUNDS |
| WO2014069649A1 (en) | 2012-10-29 | 2014-05-08 | Shionogi & Co., Ltd. | Processes for production of intermediates for 2-alkyl cephem compounds |
| JPWO2014104148A1 (en) * | 2012-12-26 | 2017-01-12 | 塩野義製薬株式会社 | Cephem compound |
| US10376496B2 (en) | 2013-09-09 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| SG11201606711UA (en) | 2014-03-24 | 2016-10-28 | Novartis Ag | Monobactam organic compounds for the treatment of bacterial infections |
| JP6377570B2 (en) * | 2014-04-28 | 2018-08-22 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Pharmaceutical composition containing 2-substituted cephem compound |
| ES2874579T3 (en) | 2014-06-11 | 2021-11-05 | Venatorx Pharmaceuticals Inc | Beta-lactamase inhibitors |
| CN106795176B (en) * | 2014-09-04 | 2020-11-10 | 盐野义制药株式会社 | Salt of cephalosporin derivative, crystalline solid thereof and process for producing the same |
| KR101935186B1 (en) * | 2014-09-04 | 2019-01-03 | 시오노기세야쿠 가부시키가이샤 | Pharmaceutical preparation comprising cephalosporin having catechol groups |
| JP6783497B2 (en) * | 2014-09-04 | 2020-11-11 | 塩野義製薬株式会社 | Intermediate of cephalosporin derivative and its production method |
| EP3307725A1 (en) | 2015-06-11 | 2018-04-18 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
| ES2817537T3 (en) | 2015-09-23 | 2021-04-07 | Novartis Ag | Salts and solid forms of a monobactam antibiotic |
| WO2017096472A1 (en) | 2015-12-10 | 2017-06-15 | Naeja-Rgm Pharmaceuticals Inc. | Cephem compounds, their production and use |
| ES2881776T3 (en) | 2016-03-08 | 2021-11-30 | Novartis Ag | Tricyclic compounds useful for treating orthomyxovirus infections |
| CN109310682A (en) * | 2016-06-17 | 2019-02-05 | 沃克哈特有限公司 | Bactericidal composition |
| JOP20170169A1 (en) | 2016-08-29 | 2019-01-30 | Novartis Ag | Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections |
| WO2018218154A1 (en) | 2017-05-26 | 2018-11-29 | VenatoRx Pharmaceuticals, Inc. | Penicillin-binding protein inhibitors |
| CA3066661A1 (en) * | 2017-06-09 | 2018-12-13 | Fob Synthesis, Inc. | Carbapenem compounds and compositions for the treatment of bacterial infections |
| AU2018311521B2 (en) | 2017-08-02 | 2022-03-03 | Novartis Ag | Process for preparing 1 -(((Z)-(1 -(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-y l)methyl)-1 -sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid |
| PE20210403A1 (en) | 2018-02-28 | 2021-03-02 | Novartis Ag | DERIVATIVES OF 10- (DI (PHENYL) METHYL) -4-HYDROXY-8,9,9A, 10-TETRAHYDRO-7H-PYRROLO [1 ', 2': 4,5] PIRAZINE [1,2-B] PYRIDAZINE- 3,5-DIONA AND RELATED COMPOUNDS AS INHIBITORS OF THE REPLICATION OF ORTHOMYXOVIRUS FOR THE TREATMENT OF INFLUENZA |
| WO2020184399A1 (en) * | 2019-03-08 | 2020-09-17 | 塩野義製薬株式会社 | Antibacterial pharmaceutical composition |
| BR112022004107A2 (en) * | 2019-09-06 | 2022-05-31 | Nabriva Therapeutics GmbH | Siderophore cephalosporin conjugates and their uses |
| KR20220130725A (en) * | 2020-01-22 | 2022-09-27 | 상하이 센후이 메디슨 컴퍼니 리미티드 | Cephalosporin antibacterial compounds and pharmaceutical applications thereof |
| TW202220663A (en) | 2020-07-28 | 2022-06-01 | 日商鹽野義製藥股份有限公司 | Lyophilized formulation comprising cephalosporin having a catechol group and method for producing the same |
| US20240132518A1 (en) | 2021-01-12 | 2024-04-25 | Shanghai Senhui Medicine Co., Ltd. | Cephalosporin antibacterial compound and preparation method therefor |
| CN113698365A (en) * | 2021-08-30 | 2021-11-26 | 成都大学 | Preparation method of cefditoren side chain |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL47168A (en) | 1974-05-09 | 1979-07-25 | Toyama Chemical Co Ltd | Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same |
| JPS57118588A (en) | 1981-11-26 | 1982-07-23 | Toyama Chem Co Ltd | Novel cephalosporin |
| DE3207840A1 (en) | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "CEPHALOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF" |
| DE3470314D1 (en) | 1983-01-21 | 1988-05-11 | Beecham Group Plc | Beta-lactam antibacterial agents |
| NO165842C (en) | 1984-04-23 | 1991-04-17 | Takeda Chemical Industries Ltd | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CEFEM COMPOUNDS. |
| EP0168177A3 (en) | 1984-06-28 | 1987-04-01 | Pfizer Limited | Cephalosporin antibiotics |
| EP0203271B1 (en) | 1985-03-01 | 1993-05-26 | Takeda Chemical Industries, Ltd. | Antibacterial compounds, their production and use |
| JPH068300B2 (en) | 1985-08-02 | 1994-02-02 | 萬有製薬株式会社 | New cefalosporin derivative |
| EP0211656A3 (en) | 1985-08-10 | 1988-03-09 | Beecham Group Plc | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
| JPH07107069B2 (en) * | 1985-09-03 | 1995-11-15 | 大塚化学株式会社 | Novel derivative of cefalosporin compound, process for producing the same and pharmaceutical composition containing the derivative |
| ATE82976T1 (en) * | 1985-09-03 | 1992-12-15 | Otsuka Kagaku Kk | CEPHALOSPORIN DERIVATIVES. |
| JPS62158291A (en) * | 1986-01-07 | 1987-07-14 | Sagami Chem Res Center | Cephalosporin derivative |
| ATE92927T1 (en) * | 1986-04-14 | 1993-08-15 | Banyu Pharma Co Ltd | 1-CARBOXY-1-VINYLOXYIMINOAMINOTHIAZOLCEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION. |
| DE3750411T2 (en) | 1986-04-14 | 1995-03-16 | Banyu Pharma Co Ltd | Cephalosporin derivatives, processes for their preparation and antibacterial preparations. |
| IE61679B1 (en) * | 1987-08-10 | 1994-11-16 | Fujisawa Pharmaceutical Co | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
| GB8719875D0 (en) | 1987-08-22 | 1987-09-30 | Beecham Group Plc | Compounds |
| JPH0228185A (en) | 1988-04-14 | 1990-01-30 | Tanabe Seiyaku Co Ltd | Cephalosporin compound and synthetic intermediate thereof |
| GB8811055D0 (en) | 1988-05-10 | 1988-06-15 | Ici Plc | Antibiotic compounds |
| US5149803A (en) * | 1988-05-10 | 1992-09-22 | Imperial Chemical Industries Plc | Intermediates for cephalosporin compounds |
| PH25965A (en) | 1988-06-06 | 1992-01-13 | Fujisawa Pharmaceutical Co | New cephem compounds which have antimicrobial activities |
| US5244890A (en) * | 1988-06-06 | 1993-09-14 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| GB8813945D0 (en) | 1988-06-13 | 1988-07-20 | Fujisawa Pharmaceutical Co | New cephem compounds & process for preparation thereof |
| GB8817653D0 (en) | 1988-07-25 | 1988-09-01 | Fujisawa Pharmaceutical Co | New cephem compounds & processes for preparation thereof |
| JPH02275886A (en) | 1988-12-29 | 1990-11-09 | Tanabe Seiyaku Co Ltd | Cephalosporin compound and its production |
| CA2005787A1 (en) | 1988-12-29 | 1990-06-29 | Masao Wada | Cephalosporin compounds |
| US5143910A (en) * | 1989-09-07 | 1992-09-01 | Shionogi & Co., Ltd. | Piperaziniocephalosporins |
| GB9005246D0 (en) | 1990-03-08 | 1990-05-02 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| US5126336A (en) | 1990-08-23 | 1992-06-30 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| US5234920A (en) | 1990-08-23 | 1993-08-10 | Bristol-Myers Squibb Company | Antibiotic C-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
| US5095012A (en) | 1990-08-23 | 1992-03-10 | Bristol-Myers Squibb Company | Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
| US5194433A (en) * | 1990-11-13 | 1993-03-16 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| GB9111406D0 (en) | 1991-05-28 | 1991-07-17 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| GB9118672D0 (en) | 1991-08-30 | 1991-10-16 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| EP0628562A1 (en) | 1993-06-10 | 1994-12-14 | Roussel Uclaf | Cephalospornis having in position 7 as substituted axymino radical, intermediates, processes for their preparation and their use as medicaments |
| WO1999033839A1 (en) | 1997-12-26 | 1999-07-08 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds |
| EP1379523B1 (en) | 2001-03-27 | 2005-07-27 | Actelion Pharmaceuticals Ltd. | 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| JP2003078440A (en) | 2001-08-30 | 2003-03-14 | Kyocera Corp | High frequency switch circuit |
| TW200305422A (en) | 2002-03-18 | 2003-11-01 | Shionogi & Co | Broad spectrum cefem compounds |
| US6713625B2 (en) | 2002-05-23 | 2004-03-30 | Orchid Chemicals & Pharmaceuticals Ltd. | Process for the preparation of cefditoren using the thioester of thiazolylacetic acid |
| JP4892926B2 (en) | 2005-10-25 | 2012-03-07 | 宇部興産株式会社 | Process for producing sulfonated aromatic block copolymer |
| JP3928086B2 (en) | 2005-03-29 | 2007-06-13 | 塩野義製薬株式会社 | 3-propenyl cephem derivative |
| JP4557859B2 (en) | 2005-09-29 | 2010-10-06 | 富士通株式会社 | Frequency division multiplexing transmission / reception apparatus and transmission / reception method |
| WO2007096740A2 (en) | 2006-02-20 | 2007-08-30 | Orchid Research Laboratories Limited | Novel cephalosporins |
| WO2007119511A1 (en) * | 2006-03-16 | 2007-10-25 | Astellas Pharma Inc. | Cephem compounds and use as antimicrobial agents |
| PT2960244T (en) | 2008-10-31 | 2016-11-02 | Shionogi & Co | Cephalosporin having catechol group |
| US8883773B2 (en) * | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
| EP2557082A4 (en) * | 2010-04-05 | 2013-08-28 | Shionogi & Co | Cephem compound having catechol group |
| JP5852562B2 (en) * | 2010-04-28 | 2016-02-03 | 塩野義製薬株式会社 | Novel cephem derivatives |
-
2009
- 2009-10-27 PT PT151750841T patent/PT2960244T/en unknown
- 2009-10-27 WO PCT/JP2009/068400 patent/WO2010050468A1/en active Application Filing
- 2009-10-27 UA UAA201106802A patent/UA105190C2/en unknown
- 2009-10-27 MY MYPI2011001201A patent/MY155655A/en unknown
- 2009-10-27 NZ NZ591728A patent/NZ591728A/en unknown
- 2009-10-27 EA EA201170632A patent/EA019520B1/en unknown
- 2009-10-27 KR KR1020117012300A patent/KR101655961B1/en active IP Right Grant
- 2009-10-27 BR BRPI0921701A patent/BRPI0921701B8/en active IP Right Grant
- 2009-10-27 CN CN200980143827.5A patent/CN102203100B/en active Active
- 2009-10-27 ES ES09823578.1T patent/ES2564836T3/en active Active
- 2009-10-27 JP JP2010535799A patent/JP5498393B2/en active Active
- 2009-10-27 CA CA2736953A patent/CA2736953C/en active Active
- 2009-10-27 PE PE2011000941A patent/PE20120010A1/en active IP Right Grant
- 2009-10-27 PL PL15175084T patent/PL2960244T3/en unknown
- 2009-10-27 RS RS20160919A patent/RS55365B1/en unknown
- 2009-10-27 AU AU2009310959A patent/AU2009310959B2/en active Active
- 2009-10-27 LT LTEP15175084.1T patent/LT2960244T/en unknown
- 2009-10-27 ES ES15175084.1T patent/ES2602969T3/en active Active
- 2009-10-27 MX MX2011004636A patent/MX2011004636A/en active IP Right Grant
- 2009-10-27 SI SI200931549A patent/SI2960244T1/en unknown
- 2009-10-27 ME MEP-2016-246A patent/ME02666B/en unknown
- 2009-10-27 DK DK15175084.1T patent/DK2960244T3/en active
- 2009-10-27 US US13/063,878 patent/US9238657B2/en active Active
- 2009-10-27 EP EP09823578.1A patent/EP2341053B1/en active Active
- 2009-10-27 EP EP15175084.1A patent/EP2960244B1/en active Active
- 2009-10-27 HU HUE15175084A patent/HUE031802T2/en unknown
- 2009-10-30 TW TW098136792A patent/TWI535727B/en active
-
2011
- 2011-03-14 IL IL211720A patent/IL211720A/en active IP Right Grant
- 2011-03-17 ZA ZA2011/02024A patent/ZA201102024B/en unknown
- 2011-03-18 CR CR20110144A patent/CR20110144A/en unknown
- 2011-04-27 CL CL2011000939A patent/CL2011000939A1/en unknown
- 2011-04-29 MA MA33798A patent/MA32731B1/en unknown
- 2011-05-02 CO CO11053320A patent/CO6331443A2/en active IP Right Grant
-
2013
- 2013-12-16 JP JP2013259499A patent/JP2014065732A/en active Pending
-
2016
- 2016-10-27 HR HRP20161408TT patent/HRP20161408T1/en unknown
- 2016-11-07 SM SM201600397T patent/SMT201600397B/en unknown
- 2016-11-16 CY CY20161101180T patent/CY1118536T1/en unknown
-
2020
- 2020-10-13 NL NL301067C patent/NL301067I2/en unknown
- 2020-10-15 LT LTPA2020530C patent/LTPA2020530I1/en unknown
- 2020-10-15 FR FR20C1050C patent/FR20C1050I2/en active Active
- 2020-10-16 CY CY2020034C patent/CY2020034I2/en unknown
- 2020-10-19 FI FIC20200039C patent/FIC20200039I1/en unknown
- 2020-10-21 NO NO2020035C patent/NO2020035I1/en unknown
- 2020-10-21 HU HUS2000042C patent/HUS2000042I1/en unknown